… of antidepressants on the overall survival of the studied cohort of lung cancer patients [129]. …
TCAs translated to improved survival in patients with colorectal cancer or glioma showed no …

… Selective serotonin reuptake inhibitors (adjusted OR=1.00, 95% CI=0.94–1.06), tricyclic
antidepressants, serotonin-norepinephrine reuptake inhibitors, and serotonin antagonist and …

… prevention of both colorectal cancer and glioma. The same group of authors in a following
paper [73] assessed the survival of CRC patients who used TCAs post-diagnosis: the authors …

… with shorter survival in patients with gliomas, and patients with gliomas with … antidepressant
use on the risk of glioma [85,86]. Tricyclic antidepressants (TCAs) reduce the risk of glioma …

… tricyclic antidepressant (TCA) use on the survival outcomes in patients with either glioma or
colorectal cancer… For colorectal patients, post-diagnosis TCA exposure was associated with a …

… patients with either colorectal cancer or glioma, there was no significant mortality reduction
in those who used tricyclic antidepressants (… with increased survival in patients with cancer, …

… for patients above 40 years with increased risk cardiovascular disease and colorectal cancer
… chemotherapy did not have any survival benefit compared to patients not on digoxin [79]. …

… survival rate of colorectal liver metastases patients after surgical resection is up to 50%, but
only 20% of patients … inhibitor (SNRI) and tricyclic antidepressant (TCA) treat depression. The …

… treatment, which extends life in most cases. Unfortunately, tumor recurrence is nearly universal
and patients with recurrent glioblastoma typically survive <1 … approved for use in patients. …

… of using tricyclic antidepressants for mortality reduction in people with glioma or colorectal
cancer. … , examining the relationship between depression and survival in glioma. However, the …